Acquired Immunotherapy Resistance through Transcriptional Repression

The recent flood of immunotherapeutic drugs onto the market has given new hope to many afflicted with cancer. However, while harnessing the immune system to treat cancer shows great promise in some patients, for many, the response does not last long-term. Now, investigators at the Fred Hutchinson Cancer Research Center are studying why some cancers become resistant to immunotherapies, as well as using new technology to look at how cancer cells change under the pressure of immunotherapy treatment